Strategic Metals has completed a property option deal that leaves it with a significant minority stake and retained royalties in Trifecta Gold's Yukon projects.
Nova Minerals (NYSE American: NVA) has received the final equipment for its planned Alaska antimony refinery, a project supported by a $43.4 million U.S. Department of War award. The Ledger examines what stands between delivered equipment and first antimony: permits, construction and feed.
American Pacific Mining (OTCQX: USGDF) is imaging hole M26C-02 at its Madison project in Montana before drilling again. The reported grades are high, but whether the zone continues beyond existing intersections is still unproven.
Prospector Metals has finished its 2026 drilling program at the Yukon ML Project with high-grade gold intercepts. The release does not say how the 2027 program will be paid for, and that is the next question.
Azincourt Energy (OTCQB: AZURF) has begun drilling at its Snegamook uranium deposit in Labrador. The company says the work could lead to its first mineral resource estimate, but the path is long and the data is still coming in.
Sirios Resources completed Phase 1 drilling at its Cheechoo project, reporting high-grade gold intersections. The company now plans Phase 2 drilling and a resource estimate.
Stallion Uranium (OTCQB: STLNF) has restarted Phase II drilling at its Moonlite Project, moving from initial exploration to targeted structural testing. The company says the geological model is now clearer, but the ore body remains unproven.
The 2026/27 program is condemnation, pit-definition, water and geotechnical work for a bankable feasibility study. The resource is already 10.5 million tonnes of lithium carbonate equivalent on paper; the cost is not.
Westhaven's sixth batch of South Zone assays lands as the 35,000-metre program closes. The true-width caveat, the 2025 economic study and the Dundee earn-in frame what the numbers can carry.
Sernova Biotherapeutics Inc. and Seraxis Holdings Inc. have entered a definitive merger agreement to create BetaNova Biotherapeutics, a clinical-stage biotech focused on type 1 diabetes treatments.
Zentek Ltd. released a preliminary economic assessment for its Albany Graphite Project in Ontario, outlining production economics and infrastructure requirements.